Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Menopausal Disorder Treatment Market Through 2034?

The market for treating menopausal disorders has experienced robust growth in recent years. The sector, which was valued at $10.69 billion in 2024, is projected to expand to $11.47 billion in 2025, yielding a compound annual growth rate (CAGR) of 7.3%. This historic period of growth is credited to several factors. These include a rise in the senior female population, heightened awareness of health conditions related to menopause, an increased incidence of obesity which intensifies menopausal symptoms, a growing acceptance of hormone replacement therapy (HRT) and advancements in personalized medicine.

In the forthcoming years, the market size for treatments of menopausal disorders is projected to experience robust growth. By 2029, the market is anticipated to escalate to $15.2 billion at a compound annual growth rate of 7.3%. This growth during the forecasted period is credited to factors such as the rising investment in healthcare infrastructure, increasing emphasis on initiatives towards women’s health, expanding partnerships between pharmaceutical corporations and research entities, and escalating urbanization resulting in lifestyle modifications affecting menopausal health. The forecast period will also witness certain trends including a move towards natural and herbal solutions, the incorporation of AI in treatment strategies, the advent of wearable tech for immediate symptom tracking, an emphasis on comprehensive wellness programs for menopause, and surplus investment into startups focused on solutions for menopause in the women’s health sector.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24318&type=smp

What Are the Core Market Drivers Propelling Growth in the Menopausal Disorder Treatment Industry?

The menopausal disorder treatment market is predicted to experience significant growth due to an escalating need for hormone replacement therapies (HRT). This medical procedure refers to the replenishment or replacement of hormones to help manage menopausal symptoms or hormone imbalances. It particularly seems that heightened awareness and demand for effective control of these health issues is fueling the surge in hormone replacement therapies. HRT offers relief for the menopausal disorder by directly restoring estrogen and progesterone levels, aiding in reestablishing hormonal stability, and reducing distressing symptoms like hot flashes, night sweats, and mood swings, thereby enhancing overall quality of life. To illustrate, the NHS Business Services Authority (NHSBSA), a support services organization based in the UK, disclosed that the prescribed HRT items had a 22% increase, amounting to 13 million in October 2024. This was accompanied by a 12% rise in identified patients from a count of 2.3 million in 2022/23 to 2.6 million in 2023/24. Consequently, the burgeoned need for hormone replacement therapies is facilitating the growth of the menopausal disorder treatment market.

How Is the Menopausal Disorder Treatment Market Segmented?

The menopausal disorder treatment market covered in this report is segmented –

1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications

2) By Stages: Menopause, Postmenopause, Perimenopause

3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets

2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements

3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed

4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24318&type=smp

Which Regions Are Driving the Next Phase of the Menopausal Disorder Treatment Market Growth?

North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Menopausal Disorder Treatment Industry?

In the menopausal disorder treatment market, major businesses are introducing groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist drugs, which offer an effective solution for handling vasomotor symptoms without the need for hormone therapy. These avant-garde therapies that inhibit NK3 receptors are changing the way menopausal symptoms are managed, eliminating the requirement for hormones. For example, in December 2023, the Japan-based pharmaceutical company, Astellas Pharma Inc., received approval from the European Commission for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms (VMS), such as night sweats and hot flashes in women undergoing menopause. It functions by focusing on the neurons in the brain’s temperature regulation center, thereby reducing these symptoms’ frequency and severity.

View the full report here:

https://www.thebusinessresearchcompany.com/report/menopausal-disorder-treatment-global-market-report

How Is the Menopausal Disorder Treatment Market Defined and What Are Its Core Parameters?

Menopausal disorder treatment refers to the range of medical and therapeutic interventions aimed at alleviating symptoms associated with menopause, such as hot flashes, mood changes, sleep disturbances, and hormonal imbalances, to improve the overall quality of life and well-being of individuals undergoing the menopausal transition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24318

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model